Hamdy Ahmed MD 4
4 · Vincerx Pharma, Inc. · Filed May 29, 2024
Insider Transaction Report
Form 4
Hamdy Ahmed MD
DirectorPresident and CEO10% Owner
Transactions
- Award
Stock Option (right to buy)
2024-05-23+53,254→ 200,000 totalExercise: $7.38Exp: 2034-03-06→ Common Stock (53,254 underlying)
Footnotes (2)
- [F1]The option grant was approved on March 7, 2024, subject to stockholder approval of an amendment to the Vincerx Pharma, Inc. 2020 Stock Incentive Plan. The stockholders approved the amendment on May 23, 2024.
- [F2]One-third (1/3) vests on March 7, 2025, with the remainder vesting in twenty-four equal monthly installments thereafter.